QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=84A7B1B8F90E10C4BB8EF198E8862C87;jsessionid=086624F9ED561E2247AC960DF604F403;jsessionid=0F62AD57107DF9D49BFCDEB9401817EC;jsessionid=1695B1BA9C79AC59971D567D8DAC638A;jsessionid=9BD19521C9C4C9A626F4F4D53253B25D;jsessionid=378D7AD2D1F34F9497B7CC1660E08F8E;jsessionid=31A3A40EE59964783538B2171E6825BF (gene)

1. Ataxin-2 sequesters Raptor into aggregates and impairs cellular mTORC1 signaling.
2. ATXN2 is a target of N-terminal proteolysis.
3. A Case of Coexistent Spinocerebellar Ataxia Type 2 and Primary Progressive Multiple Sclerosis-Coinci…
4. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
5. TDP-43 impairs sleep in Drosophila through Ataxin-2-dependent metabolic disturbance.

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=84A7B1B8F90E10C4BB8EF198E8862C87;jsessionid=086624F9ED561E2247AC960DF604F403;jsessionid=0F62AD57107DF9D49BFCDEB9401817EC;jsessionid=1695B1BA9C79AC59971D567D8DAC638A;jsessionid=9BD19521C9C4C9A626F4F4D53253B25D;jsessionid=378D7AD2D1F34F9497B7CC1660E08F8E;jsessionid=31A3A40EE59964783538B2171E6825BF